Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report (Q33393351)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report |
scientific article |
Statements
1 reference
Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report (English)
1 reference
V Châtelet
1 reference
T Lobbedez
1 reference
V Frémeaux-Bacchi
1 reference
M Ficheux
1 reference
J Ph Ryckelynck
1 reference
B Hurault de Ligny
1 reference
1 December 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference